Estimating the costs attributable to a disease with application to ovarian cancer.
about
Clinical and Economic Burden of Peristomal Skin Complications in Patients With Recent OstomiesCost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma.The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of dementia screening (CHOICE) study: study protocol for a randomized controlled trial.Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancerCost-effectiveness of early detection of breast cancer in Catalonia (Spain).Protocol for an economic evaluation alongside the University Health Network Whiplash Intervention Trial: cost-effectiveness of education and activation, a rehabilitation program, and the legislated standard of care for acute whiplash injury in OntarTechniques for estimating health care costs with censored data: an overview for the health services researcherCost of care for cancer in a health maintenance organization.Cancer economics: on variations in the costs of treating cancer.A qualitative assessment of an online support community for ovarian cancer patients.Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancerCosts and trends in pancreatic cancer treatmentOptimizing sampling strategies for estimating quality-adjusted life years.Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.Lifetime costs of the top five cancers in Taiwan.
P2860
Q30491872-F86284DD-BDB5-4005-A89E-0CFA341C32A2Q31911601-43881640-74A3-4213-B37C-F779FCB71ED4Q33419430-AEA53FE2-80BB-4999-81E9-8F8D432EC4ABQ33677912-3295CD48-F847-4805-A36A-467BC049498FQ33909250-2B4D3D63-8ECA-439E-A0DC-DC689A9BC83CQ33973056-E5B2FDA7-ABEC-4073-89D7-B79C51FEE7B2Q34311479-9702E201-8E10-4A7C-A344-F56FA27A3DC5Q34326216-B941CE60-093D-4BFB-8511-2E036C461772Q34573052-D9A50395-AFF2-4155-BAC9-9D9E0D3F3595Q36422414-DDB4D1E8-FB20-41AC-8661-FF4D9A67975AQ36572736-26912D7A-96B1-42F1-81EA-CE2A0450C30DQ36673477-028F6A8E-D600-44CE-99FF-CD878B8FF780Q37217323-27AB01CA-2415-4711-AC7F-F2A118404396Q37246292-16969031-C9DD-425F-B648-B18BFC085E10Q39454904-5491B640-E206-454E-8996-0656DE58D9A7Q40664161-2242B1A9-C420-4793-8B04-B23D0D6B9911Q40715237-0A7A1C41-5ABE-4946-9F18-7935FCDEC085Q46635786-99769963-9AFA-43D1-9EBE-F4FC19CF7E4B
P2860
Estimating the costs attributable to a disease with application to ovarian cancer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Estimating the costs attributable to a disease with application to ovarian cancer.
@en
Estimating the costs attributable to a disease with application to ovarian cancer.
@nl
type
label
Estimating the costs attributable to a disease with application to ovarian cancer.
@en
Estimating the costs attributable to a disease with application to ovarian cancer.
@nl
prefLabel
Estimating the costs attributable to a disease with application to ovarian cancer.
@en
Estimating the costs attributable to a disease with application to ovarian cancer.
@nl
P2093
P1476
Estimating the costs attributable to a disease with application to ovarian cancer.
@en
P2093
P304
P356
10.1016/0895-4356(96)89259-6
P577
1996-01-01T00:00:00Z